Medical cannabis in Switzerland: Why access remains difficult for patients
Since 2022, doctors in Switzerland have been allowed to prescribe medical cannabis without special authorization from the Federal Office of Public Health. This legislative change was intended to significantly facilitate access for patients with chronic pain or serious illnesses. However, two years after its introduction, it has become clear that the reality for many affected individuals is more complicated than expected.
A central problem is finding a suitable medical professional. Although the law permits the prescription, many doctors remain hesitant about using cannabis as a medication. There is often a lack of sound knowledge regarding dosage and potential effects. Many patients therefore report that they have to search for a long time to find a practice willing to support such a therapy.
In addition to medical advice, there are also financial hurdles. Health insurance companies in Switzerland only cover the costs of cannabis medications in exceptional cases and after an individual review. Since the preparations are often very expensive, many patients have to bear the costs themselves. This means that medical treatment is often unaffordable for people with low incomes.
In summary, although the legal framework has been improved, the practical implementation still presents major challenges. Both the medical profession and insurers must develop closer standards in the future so that patients can receive the access to this form of therapy that they require.